Clinical trial · Interventional
Mandibular Reconstruction Bone Plate
Reliability of a 2.3mm Mandibular Reconstruction Bone Plate in Mandibular Bone Preservation
NCT06099431CI-TRIAL-00088443enrolling by invitationN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the reliability of using mandibular osteosynthesis a 2.3mm reconstruction bone plate in the maintenance of the space, contour, and mandibular bone preservation during marginal mandibular resection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mandible Tumor | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mandibular marginal resection and reconstruction | Procedure | — | UNRESOLVED |
| mandibular osteosynthesis a 2.3mm reconstruction bone plate | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Surgery/Device
- description
- Mandibular marginal resection and reconstruction using a mandibular osteosynthesis a 2.3mm reconstruction bone plate
- interventionNames
- Procedure: Mandibular marginal resection and reconstruction
- Device: mandibular osteosynthesis a 2.3mm reconstruction bone plate
Primary outcomes (3)
- measure
- Degree of pain
- timeFrame
- 1 month
- description
- The degree of pain is determined during the follow up periods according the scale of Kerkmanov and Nordenram , Mild: require one tablet of analgesics three times/ day, Moderate: require two tablets of analgesics three times/ day, Severe: require injective analgesics.
- measure
- Rate of inflammation
- timeFrame
- 1 month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * patients suffering from presence of mandibular central benign lesions indicated for marginal mandibular resection Exclusion Criteria: * systemic disease affect primary wound healing malignancy
References
Publications (0)
Data not yet available
No reference posted for this study.